Yokota Y, Sato S, Yokota M, Yokota H, Araki Y
Yokota Ob/Gyn Clinic, Maebashi, Gunma, Japan.
Fertil Steril. 2001 May;75(5):1027-9. doi: 10.1016/s0015-0282(01)01685-5.
To assess vitrification of human blastocysts.
Retrospective study of blastocyst vitrification.
A private clinic.
PATIENT(S): Twenty couples with different types of infertility.
INTERVENTION(S): Blastocysts were frozen with rapid vitrification and then transferred after thawing. We vitrified blastocysts using a modification of Ishimori's vitrification solution of ethylene glycol and dimethyl sulfoxide (VSED).
MAIN OUTCOME MEASURE(S): After thawing, survival was defined by the embryo's development morphology after 6 hours or overnight culture.
RESULT(S): Eighteen of 20 patients underwent treatment. Of 45 vitrified blastocysts, 36 survived, for a survival rate of 80% (36 of 45). The implantation rate was 21.9% (7 of 32), and the pregnancy rate (per embryo transfer cycle) was 33.3% (6 of 18). One of the pregnancies resulted in the delivery of a healthy baby.
CONCLUSION(S): Supernumerary embryos were grown in culture to blastocysts, and the survival rate of vitrified-thawed blastocysts was the same as that for slow freezing of early stage embryos. Blastocyst vitrification should prove effective for clinical treatment. The present results strongly suggest that this rapid and successful vitrification procedure will replace conventional cryopreservation in the future.
评估人类囊胚的玻璃化冷冻效果。
囊胚玻璃化冷冻的回顾性研究。
一家私立诊所。
20对患有不同类型不孕症的夫妇。
采用快速玻璃化冷冻囊胚,解冻后进行移植。我们使用改良的石森氏乙二醇和二甲基亚砜玻璃化溶液(VSED)对囊胚进行玻璃化冷冻。
解冻后,通过6小时或过夜培养后的胚胎发育形态来定义存活情况。
20例患者中有18例接受了治疗。在45个玻璃化冷冻的囊胚中,36个存活,存活率为80%(45个中的36个)。着床率为21.9%(32个中的7个),妊娠率(每胚胎移植周期)为33.3%(18个中的6个)。其中一次妊娠分娩出一个健康婴儿。
多余的胚胎在培养中发育至囊胚阶段,玻璃化冷冻-解冻囊胚的存活率与早期胚胎慢速冷冻的存活率相同。囊胚玻璃化冷冻在临床治疗中应被证明是有效的。目前的结果强烈表明,这种快速且成功的玻璃化冷冻程序在未来将取代传统的冷冻保存方法。